Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow Reinvestment Rate
Pacific Shuanglin Bio pharmacy Co Ltd cash flow reinvestment rate. Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Cash Flow Reinvestment Rate of 1.03x as of September 2025, reinvesting CN¥72.17 Million (capex CN¥72.17 Million ) from operating cash flow of CN¥70.28 Million. See Pacific Shuanglin Bio pharmacy Co Ltd (000403) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Pacific Shuanglin Bio pharmacy Co Ltd (2000–2024)
Cash flow reinvestment rate of Pacific Shuanglin Bio pharmacy Co Ltd from 2000 to 2024. Historical reinvestment intensity for Pacific Shuanglin Bio pharmacy Co Ltd across 21 annual periods. Explore debt repayment capacity of Pacific Shuanglin Bio pharmacy Co Ltd to assess how comfortably operating cash covers total debt obligations.
Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow Reinvestment Rate by Year (2000–2024)
Pacific Shuanglin Bio pharmacy Co Ltd cash flow reinvestment rate by year from 2000 to 2024. Year-by-year capital reinvestment analysis for Pacific Shuanglin Bio pharmacy Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Pacific Shuanglin Bio pharmacy Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.11x | CN¥679.47 Million | CN¥321.79 Million | CN¥520.71 Million | ▲ +115.1% |
| 2023 | 0.98x | CN¥666.48 Million | CN¥679.01 Million | CN¥377.27 Million | ▼ -18.1% |
| 2022 | 1.20x | CN¥628.64 Million | CN¥524.22 Million | CN¥378.64 Million | ▲ +1.5% |
| 2021 | 1.18x | CN¥482.46 Million | CN¥408.22 Million | CN¥326.16 Million | ▲ +17.2% |
| 2020 | 1.01x | CN¥196.48 Million | CN¥194.84 Million | CN¥40.18 Million | ▼ -2.5% |
| 2019 | 1.03x | CN¥197.41 Million | CN¥190.84 Million | CN¥41.11 Million | ▲ +201.5% |
| 2018 | 0.34x | CN¥40.02 Million | CN¥116.63 Million | CN¥35.02 Million | ▼ -91.4% |
| 2016 | 3.98x | CN¥248.83 Million | CN¥62.49 Million | CN¥98.03 Million | ▲ +334.8% |
| 2015 | 0.92x | CN¥64.39 Million | CN¥70.31 Million | CN¥59.39 Million | ▼ -0.7% |
| 2014 | 0.92x | CN¥71.05 Million | CN¥77.04 Million | CN¥71.05 Million | ▼ -48.5% |
| 2013 | 1.79x | CN¥162.99 Million | CN¥91.01 Million | CN¥162.99 Million | ▲ +22.4% |
| 2012 | 1.46x | CN¥180.28 Million | CN¥123.24 Million | CN¥180.28 Million | ▲ +158.7% |
| 2011 | 0.57x | CN¥73.58 Million | CN¥130.14 Million | CN¥73.58 Million | ▼ -84.7% |
| 2010 | 3.69x | CN¥36.46 Million | CN¥9.88 Million | CN¥36.46 Million | ▲ +487.4% |
| 2009 | 0.63x | CN¥70.29 Million | CN¥111.86 Million | CN¥70.29 Million | ▲ +8.0% |
| 2008 | 0.58x | CN¥43.59 Million | CN¥74.90 Million | CN¥43.59 Million | ▲ +776.6% |
| 2007 | 0.07x | CN¥6.31 Million | CN¥95.03 Million | CN¥6.31 Million | ▼ -53.2% |
| 2005 | 0.14x | CN¥6.95 Million | CN¥49.06 Million | CN¥6.95 Million | ▼ -74.7% |
| 2002 | 0.56x | CN¥89.09 Million | CN¥159.18 Million | CN¥89.09 Million | ▼ -29.2% |
| 2001 | 0.79x | CN¥87.96 Million | CN¥111.28 Million | CN¥87.96 Million | ▼ -61.8% |
| 2000 | 2.07x | CN¥56.62 Million | CN¥27.36 Million | CN¥56.62 Million | — |